Part 99 - Dissemination of Information on Unapproved/New Uses for Marketed Drugs, Biologics, and Devices  


Subpart A - General Information
§ 99.1 - Scope.
§ 99.3 - Definitions.
Subpart B - Information To Be Disseminated
§ 99.101 - Information that may be disseminated.
§ 99.103 - Mandatory statements and information.
§ 99.105 - Recipients of information.
Subpart C - Manufacturer's Submissions, Requests, and Applications
§ 99.201 - Manufacturer's submission to the agency.
§ 99.203 - Request to extend the time for completing planned studies.
§ 99.205 - Application for exemption from the requirement to file a supplemental application.
Subpart D - FDA Action on Submissions, Requests, and Applications
§ 99.301 - Agency action on a submission.
§ 99.303 - Extension of time for completing planned studies.
§ 99.305 - Exemption from the requirement to file a supplemental application.
Subpart E - Corrective Actions and Cessation of Dissemination
§ 99.401 - Corrective actions and cessation of dissemination of information.
§ 99.403 - Termination of approvals of applications for exemption.
§ 99.405 - Applicability of labeling, adulteration, and misbranding authority.
Subpart F - Recordkeeping and Reports
§ 99.501 - Recordkeeping and reports.